Collegium Pharmaceutical, Inc (COLL)

Pharmaceutical Preparations

Latest Price

$21.82

TTM P/E

17.32

Normalized P/E

29.44

Div Yield

Book Value

9.62

P/B Ratio

2.27

Valuation metrics

EPS: $1.73

Book value / share: $9.51

Formula: √(22.5 × EPS × BVPS)

Graham Number

$19.24

12% downside

Norm. op. income: $56M (median of 7yr)

Tax rate: 31%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$24.08

+10% upside

Base FCF: $203M (median of recent 5yr)

Growth: 23%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$419.86

+1824% upside

EPS: $1.73

Target P/E: 29×

Formula: EPS × P/E

P/E Fair Value

$50.17

+130% upside

100.0% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	5.44M	$196.0M	16.74%	+307.2K	2026-06-30
Jupiter Topco LLC	2.15M	$77.0M	6.61%	--	2026-06-30
Invesco Ltd.	1.88M	$68.0M	5.79%	+290.6K	2026-06-30
Fuller & Thaler Asset Management, Inc.	1.63M	$59.0M	5.02%	+133.2K	2026-06-30
Principal Financial Group Inc	1.63M	$59.0M	5.02%	+337.3K	2026-06-30
State Street Corp	1.53M	$55.0M	4.70%	+104.3K	2026-06-30
Massachusetts Financial Services Co	1.41M	$50.0M	4.33%	+39.6K	2026-06-30
Vanguard Capital Management LLC	1.38M	$50.0M	4.25%	+47.3K	2026-06-30
Renaissance Technologies LLC	1.37M	$49.0M	4.20%	-102.9K	2026-06-30
Eventide Asset Management, LLC	1.36M	$49.0M	4.19%	-63.1K	2026-06-30